These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19862502)

  • 1. Benzene-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the functional analysis of separated alleles in yeast, in human lung cells.
    Billet S; Paget V; Garçon G; Heutte N; André V; Shirali P; Sichel F
    Arch Toxicol; 2010 Feb; 84(2):99-107. PubMed ID: 19862502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast).
    Paget V; Lechevrel M; Sichel F
    Mutat Res; 2008 Mar; 652(1):12-9. PubMed ID: 18242117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
    Paget V; Sichel F; Garon D; Lechevrel M
    Mutat Res; 2008 Oct; 656(1-2):55-61. PubMed ID: 18725321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzo[a]pyrene, aflatoxine B₁ and acetaldehyde mutational patterns in TP53 gene using a functional assay: relevance to human cancer aetiology.
    Paget V; Lechevrel M; André V; Goff JL; Pottier D; Billet S; Garçon G; Shirali P; Sichel F
    PLoS One; 2012; 7(2):e30921. PubMed ID: 22319594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response.
    Deissler H; Kafka A; Schuster E; Sauer G; Kreienberg R; Zeillinger R
    Oncol Rep; 2004 Jun; 11(6):1281-6. PubMed ID: 15138567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors.
    Smardová J
    Neoplasma; 1999; 46(2):80-8. PubMed ID: 10466430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
    Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
    Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of chemically-induced mutations at the flounder TP53 locus, the FACIM assay.
    Cachot J; Couteau J; Frébourg T; Leboulenger F; Flaman JM
    Mutat Res; 2004 Aug; 552(1-2):51-60. PubMed ID: 15288541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and Functional Analysis of TP53 Mutations in CLL.
    Pavlova S; Smardova J; Tom N; Trbusek M
    Methods Mol Biol; 2019; 1881():63-81. PubMed ID: 30350198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
    Besaratinia A; Bates SE; Pfeifer GP
    Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
    Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of p53 tumor suppressor in yeast.
    Smardová J; Smarda J; Koptíková J
    Differentiation; 2005 Jul; 73(6):261-77. PubMed ID: 16138827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
    Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
    Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.
    Duddy PM; Hanby AM; Barnes DM; Camplejohn RS
    J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population.
    Hussain I; ul Rehman S; Afroze D; Zahoor L; Abdullah S; Hafiz A; Shah ZA; Iqbal S; Shaffi M; Das BC; Siddiqi MA
    Mutat Res; 2009 May; 676(1-2):5-10. PubMed ID: 19486858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.